Oxytocin for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 5 registered trials.

Also followed for narrower conditions: Pediatric Obesity

Why this status

  1. 3 Feb 2017: Trial registered, NCT03043053
  2. 1 Jul 2017: Trial started, NCT03043053

The trials

NCT02276677: Oxytocin Effects on Food Motivation Pathways

State
Completed
Phase
Early Phase 1
People
10 taking part
Started
Oct 2014
Primary completion
May 2015
Arms
Oxytocin
Results
None posted
  1. 28 Oct 2014: Trial registered

NCT03043053: The Effects of Oxytocin in Obese Adults

State
Completed
Phase
Phase 2
People
61 taking part
Started
1 Jul 2017
Primary completion
20 May 2022
Arms
oxytocin
Results
Posted on the registry
Papers
doi:10.1056/evidoa2300349, doi:10.1210/clinem/dgag291
  1. 3 Feb 2017: Trial registered
  2. 1 Jul 2017: Trial started
  3. 7 Jul 2022: Trial completed
  4. 7 Feb 2024: Trial results posted

NCT03119610: The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity

State
Completed
Phase
Phase 1 and Phase 2
People
23 taking part
Started
22 Sep 2017
Primary completion
17 Dec 2018
Arms
Oxytocin nasal spray
Results
Posted on the registry
Papers
doi:10.1016/j.jamda.2021.04.015
  1. 18 Apr 2017: Trial registered
  2. 22 Sep 2017: Trial started
  3. 17 Dec 2019: Trial completed
  4. 22 Oct 2020: Trial results posted

NCT05207774: Pre-operative Intranasal Oxytocin for Enhancing Bariatric-induced Diabetes Remission

State
State not given
Phase
No phase
People
3 taking part
Started
9 Jan 2020
Primary completion
30 Aug 2023
Arms
oxytocin
Results
None posted
  1. 9 Jan 2020: Trial started
  2. 26 Jan 2022: Trial registered

NCT06189001: The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with Obesity

State
Completed
Phase
No phase
People
25 taking part
Started
1 Jan 2024
Primary completion
4 Sep 2024
Arms
Oxytocin
Results
None posted
  1. 1 Jan 2024: Trial started
  2. 3 Jan 2024: Trial registered
  3. 4 Sep 2024: Trial completed

How the status changed

  1. 16 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Oxytocin nasal spray, Pitocin, Syntocinon.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.